ES2058733T3 - Metodo para mejorar la ventilacion durante el sueño y para el tratamiento de anormalidades de la ventilacion relacionadas con el sueño. - Google Patents

Metodo para mejorar la ventilacion durante el sueño y para el tratamiento de anormalidades de la ventilacion relacionadas con el sueño.

Info

Publication number
ES2058733T3
ES2058733T3 ES90122502T ES90122502T ES2058733T3 ES 2058733 T3 ES2058733 T3 ES 2058733T3 ES 90122502 T ES90122502 T ES 90122502T ES 90122502 T ES90122502 T ES 90122502T ES 2058733 T3 ES2058733 T3 ES 2058733T3
Authority
ES
Spain
Prior art keywords
sleep
ventilation
branched
chain amino
abnormalities
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90122502T
Other languages
English (en)
Inventor
Jeffrey Askanazi
Susan L Trimbo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Clintec Nutrition Co
Original Assignee
Clintec Nutrition Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/443,765 external-priority patent/US5017616A/en
Application filed by Clintec Nutrition Co filed Critical Clintec Nutrition Co
Application granted granted Critical
Publication of ES2058733T3 publication Critical patent/ES2058733T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Ventilation (AREA)
  • Control Of El Displays (AREA)
  • Treating Waste Gases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

UN METODO PARA MEJORAR LA VENTILACION DURANTE EL SUEÑO Y TRATAMIENTO DE LAS IRREGULARIDADES DE VENTILACION CON EL RELACIONADAS. CON ESTE PROPOSITO, LA INVENCION PROPORCIONA UN METODO PARA UTILIZAR UNA CADENA RAMIFICADA DE AMINOACIDOS COMO TERAPIA EFICAZ DE LA APNEA DEL SUEÑO. LA CADENA RAMIFICADA DE AMINOACIDOS PUEDE SER ADMINISTRADA BIEN DE FORMA PARENTAL O ENTERAL Y PUEDE SER ADMINISTRADA POR SI SOLA O EN COMBINACION CON OTROS NUTRIENTES LA COMPOSICION DE LA CADENA RAMIFICADA DE AMINOACIDOS DE LA INVENCION FUNCIONA, DURANTE EL SUEÑO, A MODO DE ESTIMULADOR DE LA VENTILACION Y NO PRESENTA NINGUN EFECTO NEGATIVO NI EN EL PACIENTE NI EN SU SUEÑO. PREFERENTEMENTE, LA CADENA RAMIFICADA DE AMIROACIDOS DEBE CONTENER DE UN 60 A UN 85 % DE UNA DISOLUCION AMINOACIDA LA CUAL SE ADMINISTRA AL PACIENTE.
ES90122502T 1989-11-30 1990-11-26 Metodo para mejorar la ventilacion durante el sueño y para el tratamiento de anormalidades de la ventilacion relacionadas con el sueño. Expired - Lifetime ES2058733T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/443,765 US5017616A (en) 1989-11-30 1989-11-30 Method for improving ventilation during sleep and treating sleep related ventilation abnormalities
US07/582,527 US5294642A (en) 1989-11-30 1990-09-14 Method for improving ventilation during sleep and treating sleep related ventilation abnormalities

Publications (1)

Publication Number Publication Date
ES2058733T3 true ES2058733T3 (es) 1994-11-01

Family

ID=27033652

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90122502T Expired - Lifetime ES2058733T3 (es) 1989-11-30 1990-11-26 Metodo para mejorar la ventilacion durante el sueño y para el tratamiento de anormalidades de la ventilacion relacionadas con el sueño.

Country Status (8)

Country Link
US (1) US5294642A (es)
EP (1) EP0434989B1 (es)
JP (1) JPH03181416A (es)
AT (1) ATE92757T1 (es)
AU (1) AU626184B2 (es)
DE (1) DE69002743T2 (es)
DK (1) DK0434989T3 (es)
ES (1) ES2058733T3 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5278190A (en) * 1989-11-30 1994-01-11 Clintec Nutrition Co. Method for improving the quality of sleep and treating sleep disorders
US5140045A (en) * 1989-11-30 1992-08-18 Clintec Nutrition Co. Method for improving ventilation during sleep and treating sleep related ventilation abnormalities of neonates
US5728678A (en) * 1995-06-06 1998-03-17 Nestec Ltd. Method and composition for providing nutrition to a renal failure patient
AU2017357747A1 (en) 2016-11-10 2019-05-30 The Research Foundation For The State University Of New York System, method and biomarkers for airway obstruction

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767785A (en) * 1984-01-18 1988-08-30 Michael Georgieff Hypocaloric preparation and intravenous method for hypocaloric treatment of patients
US5017616A (en) * 1989-11-30 1991-05-21 Jeffrey Askanazi Method for improving ventilation during sleep and treating sleep related ventilation abnormalities

Also Published As

Publication number Publication date
DK0434989T3 (da) 1993-12-27
AU626184B2 (en) 1992-07-23
DE69002743T2 (de) 1993-11-25
US5294642A (en) 1994-03-15
JPH03181416A (ja) 1991-08-07
EP0434989A1 (en) 1991-07-03
ATE92757T1 (de) 1993-08-15
EP0434989B1 (en) 1993-08-11
AU6666490A (en) 1991-06-06
DE69002743D1 (de) 1993-09-16

Similar Documents

Publication Publication Date Title
EP1201241B8 (en) Compositions containing capsaicin or capsaicin analogues and an anesthetic
DE69836352D1 (de) Transdermales therapeutisches Pflaster mit Capsaicin und seinen Analogen
DE69122099D1 (de) Zusammensetzung und verfahren zur prävention und behandlung von hypercholesterinämie und zellproliferationsstorungen
SE8703625D0 (sv) New medical use
EP0502925A4 (en) Method and composition for treating inflammatory bowel disorders
NZ218607A (en) Tri-to acta-peptides with sulphate ester groups: obesity treatment
BR9814048A (pt) "misturas de enantiÈmetros de aminociclohexil amidas para produzir de modo simultâneo analgesia com anestesia local ou antiarritmia "
DE69021257D1 (de) Verwendung von IFN-gamma zur Herstellung einer pharmazeutischen Zusammensetzung für die Behandlung von ATL.
KR970009582B1 (en) Method for the treatment of oste oporosis and related disorders
DK0434989T3 (da) Fremgangsmåde til forbedring af ventilationen under søvn og til behandling af søvnrelaterede ventilationsabnormaliteter
DE69207479D1 (de) Verwendung der Ester von Acyl-L-Carnitin mit Gamma-Hydroxy-Buttersäure zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von Lebererkrankungen
ATE200734T1 (de) Zusammensetzung und verfahren zur verminderung des hypotensionsrisikos
MY104521A (en) Treatment of depression.
GR3017321T3 (en) Use of amino acids for the protection of and metabolic recovery of ischemic cardiac tissue.
MX9700967A (es) Uso terapeutico de acetazolamida para el tratamiento de edema cerebral.
ATE31022T1 (de) Verwendung von 4,5'-azo-bis-salicylsaeure zur herstellung eines arzneimittels zur behandlung entzuendlicher darmkrankheiten.
YU118389A (en) Derivatives of proponol amine and process for obtaining thereof
ATE40795T1 (de) Verwendung eines zerebral und peripher wirkenden antihypoxidotikums.
IT1157276B (it) Composizione per supplire provvisoriamente a difetti del tessuto osseo
CN1050824A (zh) 一种根治白癜风病的药的配制方法
IT1261938B (it) Uso di acidi carbossilici con da 7 a 13 atomi di carbonio o loro sali fisiologicamente accettabili per la produzione di un medicinale per il trattamento topico delle osteomieliti antibiotico-resistenti.
IL71819A (en) Pharmaceutical composition for treatment of neurological disease or aging containing amino acids together with choline
DE3786442D1 (de) Verwendung von follikelreifungshormon zur herstellung eines therapeutischen mittels zur behandlung von neoplasmen von gonadalem ursprung.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 434989

Country of ref document: ES